Decision making for HIV prevention and treatment scale up: Bridging the gap between theory and practice

Medical Decision Making

Volumn 32, Issue 1, 2012, Pages 105-117

  Alistar, Sabina S ^a   Brandeau, Margaret L ^a  

^a Stanford University   (United States)

Author keywords

AIDS; bioterrorism and disaster preparedness; cost utility analysis; cost benefit analysis (CBA); HIV; infectious disease

Indexed keywords

ARTICLE; DECISION MAKING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORGANIZATION AND MANAGEMENT; RESOURCE ALLOCATION; THEORETICAL MODEL;

DECISION MAKING; FEMALE; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; RESOURCE ALLOCATION;

EID: 84856598014     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X10391808     Document Type: Conference Paper

References (98)

1. 2008 Report on the Global AIDS Epidemic. Geneva (Switzerland): World Health Organization ; 2008 :
2. Merson MH. The HIV-AIDS pandemic at 25-the global response. N Engl J Med. 2006 ; 354 (23). 2414-7 (Pubitemid 43855044)
3. The Millennium Development Goals Report 2009. New York: United Nations ; 2009 :
4. United Nations Millennium Declaration. New York: United Nations ; 2000 :
5. What Countries Need: Investments Needed for 2010 Targets. Geneva (Switzerland): UNAIDS ; 2009 :
6. Public Health Aspects of HIV/AIDS in Low and Middle Income Countries. Celentano DD Davis WW Beyrer C, ed. New York: Springer ; 2008: 3-17.
7. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector-Progress Report 2009. Geneva (Switzerland): World Health Organization ; 2009 :
8. Stover J, Bertozzi S, Gutierrez J-P, et al. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science. 2006 ; 311 (5766). 1474-6 (Pubitemid 43376704)
9. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. Geneva (Switzerland): World Health Organization, UNAIDS, UNICEF ; 2008 :
10. Bringing HIV Prevention to Scale: An Urgent Global Priority. Washington (DC): Global HIV Prevention Working Group ; 2007 :
11. Merson MH, O'Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet. 2008 ; 372 (9637). 475-88
12. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008 ; 372 (9639). 669-84
13. Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet. 2008 ; 372 (9641). 845-59
14. Horton R, Das P. Putting prevention at the forefront of HIV/AIDS. Lancet. 2008 ; 372 (9637). 421-2
15. Collins C, Coates TJ, Curran J. Moving beyond the alphabet soup of HIV prevention. AIDS. 2008 ; 22 (Suppl 2). S5 - S8
16. Joint United Nations Programme on HIV/AIDS (UNAIDS). Resource needs for an expanded response to AIDS in low- and middle-income countries. 2005. Available from: URL: http://data.unaids.org/publications/irc-pub06/ resourceneedsreport-en.pdf. Accessed 22 July 2009.
17. Schmid C, McColl W The AIDS Drug Assistance Program: Securing HIV/AIDS Drugs for the Nation's Poor and Uninsured. Washington (DC): The AIDS Institute and the AIDS Action Foundation ; 2008 :
18. Bassett IV, Farel C, Szmuilowicz ED, Walensky RP. HIV/AIDS: AIDS drug assistance programs in the era of routine HIV testing. Clin Infect Dis. 2008 ; 47 (5). 695-701
19. Averting a Human Crisis during the Global Downturn: Policy Options from the World Bank's Human Development Network. Washington (DC): The World Bank ; 2009 :
20. HIV Prevention Needs and Successes: A Tale of Three Countries. An Update on HIV Prevention Success in Senegal, Thailand and Uganda. Geneva (Switzerland): UNAIDS ; 2001 :
21. No Time to Lose: Getting More from HIV Prevention. Washington (DC): Institute of Medicine, Division of Health Promotion and Disease Prevention ; 2001 :
22. Kerr T, Wodak A, Elliott R, Montaner JS, Wood E. Opioid substitution and HIV/AIDS treatment and prevention. Lancet. 2004 ; 364 (9449). 1918-9 (Pubitemid 39574577)
23. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001 ; 15 (11). 1329-41 (Pubitemid 32662285)
24. McFarlane DR. Reproductive health policies in President Bush's second term: old battles and new fronts in the United States and internationally. J Public Health Policy. 2006 ; 27 (4). 405-26
25. HIV prevention policy needs an urgent cure. Lancet. 2006 1213 ; 367 ( 9518 ):
26. Nelson R. Report shows mixed results for PEPFAR. Lancet Infect Dis. 2006 ; 6 (4). 194
27. Bertozzi SM, Laga M, Bautista-Arredondo S, Coutinho A. Making HIV prevention programmes work. Lancet. 2008 ; 372 (9641). 831-44
28. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ. 2005 ; 331 (7530). 1431-7
29. Hillier FS, Lieberman GJ Introduction to Operations Research. Boston: McGraw-Hill ; 2005 :
30. Lasry A, Richter A, Lutscher F. Recommendations for increasing the use of HIV/AIDS resource allocation models. BMC Public Health. 2009 ; 9 (Suppl 1). S8
31. Lasry A, Carter MW, Zaric GS. S4HARA: system for HIV/AIDS resource allocation. Cost Eff Resour Alloc. 2008 ; 6: 7
32. Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics, part I. Proc R Stat Soc A. 1927 ; 115: 700-21
33. Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics, part II. Proc R Stat Soc A. 1932 ; 138: 55-83
34. Kaplan EH Handbook of Economic Evaluation of HIV Prevention Programs. Holtgrave DR, ed. New York: Plenum Press ; 1998 :
35. Hethcote HW. The mathematics of infectious diseases. SIAM Review. 2000 ; 42 (4). 599-653
36. Hethcote HW. Qualitative analyses of communicable disease models. Math Biosci. 1976 ; 28: 335-56
37. Wickwire K. Mathematical models for the control of pests and infectious diseases: a survey. Theor Popul Biol. 1977 ; 11 (2). 182-238
38. Sethi SP. Optimal quarantine programmes for controlling an epidemic spread. J Oper Res Soc. 1978 ; 29 (3). 265-8
39. Sethi SP, Preston WS. Optimal control of some simple deterministic epidemic models. J Oper Res Soc. 1978 ; 29 (2). 129-36
40. Greenhalgh D. Control of an epidemic spreading in a heterogeneously mixing population. Math Biosci. 1986 ; 80 (1). 23-45 (Pubitemid 16058992)
41. Friedrich CM, Brandeau ML Proceedings of the 1998 Medical Sciences Simulation Conference. Anderson JG Katzper M, ed. San Diego (CA): Society for Computer Simulation International ; 1998 :
42. Richter A, Brandeau ML, Owens DK. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users. Med Decis Making. 1999 ; 19 (2). 167-79 (Pubitemid 29318146)
43. Revelle C, Feldmann F, Lynn W. An optimization model of tuberculosis epidemiology. Manage Sci. 1969 ; 16 (4). B190-211
44. Longini IM, Ackerman E, Elveback LR. An optimization model for influenza A epidemics. Math Biosci. 1978 ; 38 (1-2). 141-57 (Pubitemid 8313376)
45. Hethcote HW, Yorke JA, Nold A. Gonorrhea modeling: a comparison of control methods. Math Biosci. 1982 ; 58 (1). 93-109 (Pubitemid 12109810)
46. Brandeau ML Operations Research and Health Care: Methods and Applications. Brandeau ML Sainfort F Pierskalla WP, ed. Norwell (MA): Kluwer Academic Publishers ; 443-64.
47. Zaric GS. Resource allocation for control of infectious disease epidemics. Comments on Theoretical Biology. 2003 ; 8: 475-96
48. Dandona L, Kumar SP, Ramesh Y, et al. Changing cost of HIV interventions in the context of scaling-up in India. AIDS. 2008 ; 22 (Suppl 1). S43-9
49. Dandona L, Sisodia P, Kumar S, et al. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health. 2005 ; 5: 98
50. Guinness L, Kumaranayake L, Hanson K. A cost function for HIV prevention services: is there a "u"-shape?. Cost Eff Resour Alloc. 2007 ; 5: 13
51. Kaplan EH. Economic analysis of needle exchange. AIDS. 1995 ; 9 (10). 1113-9
52. Marseille E, Dandona L, Marshall N, et al. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res. 2007 ; 7 (1). 108
53. Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes. Pharmacoeconomics. 2008 ; 26 (3). 191-215
54. Long EF, Brandeau ML Tutorials in Operations Research. Gray P, ed. Baltimore: Institute for Operations Research and the Management Sciences (INFORMS) ; 2009: 123-38.
55. No Time to Lose: Getting More from HIV Prevention. Ruiz M Gable A Kaplan EH, ed. Washington (DC): National Academy Press ; 2001 :
56. Martello S, Toth P Knapsack Problems: Algorithms and Computer Implementations. New York: Wiley ; 1990 :
57. Kaplan EH, Pollack H. Allocating HIV prevention resources. Socio-Econ Plann Sci. 1998 ; 32 (4). 257-63 (Pubitemid 28497379)
58. Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?. Am J Public Health. 1996 ; 86 (12). 1709-12
59. Paltiel D Modeling the AIDS Epidemic: Planning, Policy, and Prediction. Kaplan EH Brandeau ML, ed. New York: Raven Press ; 1994: 53-71.
60. Zaric GS, Brandeau ML. Resource allocation for epidemic control over short time horizons. Math Biosci. 2001 ; 171 (1). 33-58 (Pubitemid 32429042)
61. Anderson RM, May RM Infectious Diseases of Humans: Dynamics and Control. Oxford (UK): Oxford University Press ; 1991 :
62. Bernstein RS, Sokal DC, Seitz ST, Auvert B, Stover J, Naamara W. Simulating the control of a heterosexual HIV epidemic in a severely affected East African city. Interfaces. 1998 ; 28 (3). 101-26
63. Robinson NJ, Mulder DW, Auvert B, Hayes RJ. Modelling the impact of alternative HIV intervention strategies in rural Uganda. AIDS. 1995 ; 9 (11). 1263-70
64. Bautista-Arredondo S, Gadsden P, Harris JE, Bertozzi SM. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework. AIDS. 2008 ; 22: S67-74
65. Brandeau ML, Zaric GS. Optimal investment in HIV prevention programs: more is not always better. Health Care Manage Sci. 2009 ; 12 (1). 27-37
66. Kumaranayake L. The economics of scaling up: cost estimation for HIV/AIDS interventions. AIDS. 2008 ; 22: S23-33
67. Brandeau ML, Zaric GS, De Angelis V. Improved allocation of HIV prevention resources: using information about prevention program production functions. Health Care Manage Sci. 2005 ; 8 (1). 19-28 (Pubitemid 40468919)
68. Castilla J, del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J AIDS. 2005 ; 40 (1). 96-101 (Pubitemid 41233212)
69. Egger M, May M, Chêne G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002 ; 360 (9327). 119-29 (Pubitemid 34786200)
70. Grabar S, Moing VL, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med. 2000 ; 133 (6). 401-10
71. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997 ; 336 (15). 1072-8 (Pubitemid 27163861)
72. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JSG. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0. 350 × 109 cells/L. Ann Intern Med. 2003 ; 139 (10). 810-6
73. Cleary SM, McIntyre D, Boulle AM. Assessing efficiency and costs of scaling up HIV treatment. AIDS. 2008 ; 22 (Suppl 1). S35-42
74. Broomberg J, Söderlund N, Mills A. Economic analysis at the global level: a resource requirement model for HIV prevention in developing countries. Health Policy. 1996 ; 38 (1). 45-65 (Pubitemid 26271123)
75. El-Sadr WM, Abrams EJ. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings?. AIDS. 2007 ; 21 (Suppl 5). S65-70
76. Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet. 2008 ; 372 (9640). 764-75
77. Rauner MS, Brandeau ML. AIDS policy modeling for the 21st century: an overview of key issues. Health Care Manage Sci. 2001 ; 4 (3). 165-80
78. Hirschhorn LR, Ojikutu B, Rodriguez W. Research for change: using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings. J Infect Dis. 2007 ; 196 (S3). S516-22
79. UNAIDS Practical Guidelines for Intensifying HIV Prevention: Towards Universal Access. Geneva (Switzerland): UNAIDS ; 2007 :
80. Wilson D, Halperin DT. "Know your epidemic, know your response": a useful approach, if we get it right. Lancet. 2008 ; 372 (9637). 423-6
81. Johnson-Masotti AP, Pinkerton SD, Holtgrave DR, Valdiserri RO, Willingham M. Decision-making in HIV prevention community planning: an integrative review. J Community Health. 2000 ; 25 (2). 95-112 (Pubitemid 30228433)
82. Kaplan EH, Merson MH. Allocating HIV-prevention resources: balancing efficiency and equity. Am J Public Health. 2002 ; 92 (12). 1905-7 (Pubitemid 35386612)
83. Centers for Disease Control and Prevention. HIV prevention community planning process. 2006. Available from: URL: http://www.cdc.gov/hiv/topics/cba/ resources/guidelines/hiv-cp/section3.htm. Accessed 14 June 2010.
84. Kerr NL, Tindale RS. Group performance and decision making. Ann Rev Psychol. 2004 ; 55: 623-55
85. Zaric GS, Brandeau ML. Optimal investment in a portfolio of HIV prevention programs. Med Decis Making. 2001 ; 21 (5). 391-408 (Pubitemid 32862106)
86. Joint United Nations Programme on HIV/AIDS (UNAIDS). Epidemiological software and tools. 2009. Available from: URL: http://www.unaids.org/en/ KnowledgeCentre/HIVData/Epidemiology/EPI-software2009.asp. Accessed 174 June 2010.
87. Family Health International. AVERT: a tool for estimating intervention effects on the reduction of HIV transmission. 2009. Available from: URL: http://www.fhi.org/en/hivaids/pub/guide/avert.htm. Accessed 10 September 2009.
88. Futures Institute. Decision-makers' programme planning tool for male circumcision scale-up. 2009. Available from: URL: http://www.futuresinstitute. org/pages/MaleCircumcision.aspx. Accessed 10 September 2009.
89. Earnshaw SR, Hicks K, Richter A, Honeycutt A. A linear programming model for allocating HIV prevention funds with state agencies: a pilot study. Health Care Manage Sci. 2007 ; 10 (3). 239-52
90. Richter A, Hicks KA, Earnshaw SR, Honeycutt AA. Allocating HIV prevention resources: a tool for state and local decision making. Health Policy. 2008 ; 87 (3). 342-9
91. Stover J, Bollinger L, Cooper-Arnold K GOALS model for estimating the effects of resource allocation decisions on the achievement of the goals of the HIV/AIDS strategic plan. Washington (DC): The Futures Group International ; 2003 :
92. Stover J, Walker N, Garnett GP, et al. Can we reverse the HIV/AIDS pandemic with an expanded response?. Lancet. 2002 ; 360: 73
93. Brandeau ML, McCoy JH, Hupert NA, Holty J-E, Bravata DM. Recommendations for modeling crisis response in public health and medicine: a position paper of the Society for Medical Decision Making. Med Decis Making. 2009 ; 29: 438-60
94. Centers for Disease Control and Prevention. FluSurge 2.0. 2006. Available from: URL: http://www.cdc.gov/flu/tools/flusurge/. 22July2009.
95. Centers for Disease Control and Prevention. FluAid 2.0. 2000. Available from: URL: www.cdc.gov/flu/tools/fluaid. Accessed 22 July 2009.
96. Agency for Healthcare Research and Quality. The Weill/Cornell Bioterrorism and Epidemic Outbreak Response Model (BERM). 2003. Available from: URL: http://www.ahrq.gov/research/biomodel/index.asp. 10September2009.
97. University of Maryland and the Advanced Practice Center for Public Health Emergency Preparedness and Response of Montgomery County Maryland. Software for improving mass dispensing and vaccination clinic operations. 2008. Available from: URL: http://www.isr.umd.edu/Labs/CIM/projects/clinic/software.html. Accessed 13 April 2010.
98. ColvinMGorgens-AlbinoMKaseddeS. Analysis of HIV prevention response and modes of transmission: the UNAIDS-GAMET supported synthesis process. 2008. Available from: www.unaidsrstesa.org/files/MoT-0.pdfhttp://www.unaidsrstesa.org/ files/MoT-0.pdf. Accessed 10 September 2009.